Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer.

Topkan E, Selek U, Ozdemir Y, Yildirim BA, Guler OC, Mertsoylu H, Hahn SM.

Lung Cancer. 2018 Jul;121:30-36. doi: 10.1016/j.lungcan.2018.04.016. Epub 2018 Apr 21.

PMID:
29858023
2.

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.

Yang J, Xu T, Gomez DR, Yuan X, Nguyen QN, Jeter M, Song Y, Komaki R, Hu Y, Hahn SM, Liao Z.

Cancer Med. 2018 Jun;7(6):2247-2255. doi: 10.1002/cam4.1349. Epub 2018 May 9.

3.

Qualitative Assessment of Academic Radiation Oncology Department Chairs' Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations.

Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Movsas B, Kalnicki S, Formenti SC, Thomas CR Jr, Hahn SM, Liu FF, Jagsi R; Society of Chairs of Academic Radiation Oncology Programs (SCAROP).

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):30-45. doi: 10.1016/j.ijrobp.2018.01.012. Epub 2018 Jan 9.

PMID:
29477292
4.

Improving immune-vascular crosstalk for cancer immunotherapy.

Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W.

Nat Rev Immunol. 2018 Mar;18(3):195-203. doi: 10.1038/nri.2017.145. Epub 2018 Jan 15. Review.

PMID:
29332937
5.

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.

JAMA Oncol. 2018 Aug 1;4(8):e174504. doi: 10.1001/jamaoncol.2017.4504. Epub 2018 Aug 9.

PMID:
29302695
6.

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR Jr, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R.

J Clin Oncol. 2018 Jun 20;36(18):1813-1822. doi: 10.1200/JCO.2017.74.0720. Epub 2018 Jan 2.

PMID:
29293386
7.

Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era.

Pezzi TA, Tang C, Swanick CW, Fang P, Hess K, Xu T, Hahn SM, Chang JY, Liao Z, Gomez D.

Radiother Oncol. 2017 Nov;125(2):325-330. doi: 10.1016/j.radonc.2017.09.018. Epub 2017 Oct 17.

PMID:
29054376
8.

Clinical Risk Factors Influencing Dental Developmental Disturbances in Childhood Cancer Survivors.

Kang CM, Hahn SM, Kim HS, Lyu CJ, Lee JH, Lee J, Han JW.

Cancer Res Treat. 2018 Jul;50(3):926-935. doi: 10.4143/crt.2017.296. Epub 2017 Oct 10.

9.

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.

Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB 2nd, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ.

Front Oncol. 2017 Sep 5;7:201. doi: 10.3389/fonc.2017.00201. eCollection 2017. No abstract available.

10.

Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs.

Holliday EB, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR Jr.

J Healthc Manag. 2017 Sep/Oct;62(5):302-313. doi: 10.1097/JHM-D-16-00001.

PMID:
28885530
11.

Immune Priming of the Tumor Microenvironment by Radiation.

Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM.

Trends Cancer. 2016 Nov;2(11):638-645. doi: 10.1016/j.trecan.2016.09.007. Epub 2016 Oct 15. Review.

PMID:
28741502
12.

Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.

DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, Yeap BY, Hahn SM, De Amorim Bernstein K, Nielsen GP, Choy E, Mullen JT, Yoon SS.

Adv Radiat Oncol. 2017 Jan 4;2(1):85-93. doi: 10.1016/j.adro.2016.12.003. eCollection 2017 Jan-Mar.

13.

A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma.

Guttmann DM, Frick MA, Carmona R, Deville C Jr, Levin WP, Berman AT, Chinniah C, Hahn SM, Plastaras JP, Simone CB 2nd.

Radiother Oncol. 2017 Aug;124(2):271-276. doi: 10.1016/j.radonc.2017.06.024. Epub 2017 Jul 8.

PMID:
28697854
14.

Factors Associated with Emotional Distress in Children and Adolescents during Early Treatment for Cancer.

Sohn IJ, Han JW, Hahn SM, Song DH, Lyu CJ, Cheon KA.

Yonsei Med J. 2017 Jul;58(4):816-822. doi: 10.3349/ymj.2017.58.4.816.

15.

The Rise of Radiomics and Implications for Oncologic Management.

Verma V, Simone CB 2nd, Krishnan S, Lin SH, Yang J, Hahn SM.

J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djx055.

PMID:
28423406
16.

7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.

Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, Allen PK, Balter PA, Welsh JD, O'Reilly MS, Gomez D, Hahn SM, Roth JA, Mehran RJ, Heymach JV, Chang JY.

Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.

17.

Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.

Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JY.

J Thorac Oncol. 2017 Jun;12(6):983-992. doi: 10.1016/j.jtho.2017.02.018. Epub 2017 Mar 1.

18.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, Jeter M, Welsh JW, O'Reilly MS, Gomez DR, Hahn SM, Heymach JV, Rice DC, Chang JY.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):900-907. doi: 10.1016/j.ijrobp.2016.12.022. Epub 2016 Dec 21.

19.

Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.

Pezzi TA, Mohamed AS, Fuller CD, Blanchard P, Pezzi C, Sepesi B, Hahn SM, Gomez DR, Chun SG.

Ann Surg Oncol. 2017 May;24(5):1419-1427. doi: 10.1245/s10434-017-5786-6. Epub 2017 Feb 2.

PMID:
28154950
20.

Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.

Hwang IK, Hahn SM, Kim HS, Kim SK, Kim HS, Shin KH, Suh CO, Lyu CJ, Han JW.

Cancer Res Treat. 2017 Jul;49(3):717-726. doi: 10.4143/crt.2016.271. Epub 2016 Dec 1.

21.

Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy?

Coelho RC, Da Silva FML, Do Carmo IML, Bonaccorsi BV, Hahn SM, Faroni LD.

Breast. 2017 Feb;31:192-196. doi: 10.1016/j.breast.2016.10.026. Epub 2016 Nov 24.

PMID:
27889595
22.

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y.

ESMO Open. 2016 Sep 29;1(5):e000097. eCollection 2016. Review.

23.

Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.

Chao HH, Berman AT, Simone CB 2nd, Ciunci C, Gabriel P, Lin H, Both S, Langer C, Lelionis K, Rengan R, Hahn SM, Prabhu K, Fagundes M, Hartsell W, Mick R, Plastaras JP.

J Thorac Oncol. 2017 Feb;12(2):281-292. doi: 10.1016/j.jtho.2016.10.018. Epub 2016 Nov 5.

24.

Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.

Friedberg JS, Simone CB 2nd, Culligan MJ, Barsky AR, Doucette A, McNulty S, Hahn SM, Alley E, Sterman DH, Glatstein E, Cengel KA.

Ann Thorac Surg. 2017 Mar;103(3):912-919. doi: 10.1016/j.athoracsur.2016.08.071. Epub 2016 Nov 5.

25.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Wang X, Schoenhals JE, Li A, Valdecanas DR, Ye H, Zang F, Tang C, Tang M, Liu CG, Liu X, Krishnan S, Allison JP, Sharma P, Hwu P, Komaki R, Overwijk WW, Gomez DR, Chang JY, Hahn SM, Cortez MA, Welsh JW.

Cancer Res. 2017 Feb 15;77(4):839-850. doi: 10.1158/0008-5472.CAN-15-3142. Epub 2016 Nov 7.

26.

Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.

Zeng C, Plastaras JP, James P, Tochner ZA, Hill-Kayser CE, Hahn SM, Both S.

Acta Oncol. 2016 Sep - Oct;55(9-10):1132-1138. doi: 10.1080/0284186X.2016.1191665. Epub 2016 Jun 22.

PMID:
27332881
27.

Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025.

Pan HY, Haffty BG, Falit BP, Buchholz TA, Wilson LD, Hahn SM, Smith BD.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):493-500. doi: 10.1016/j.ijrobp.2016.02.064. Epub 2016 Mar 5.

PMID:
27209499
28.

Subclinical Hypothyroidism in Childhood Cancer Survivors.

Lee HJ, Hahn SM, Jin SL, Shin YJ, Kim SH, Lee YS, Kim HS, Lyu CJ, Han JW.

Yonsei Med J. 2016 Jul;57(4):915-22. doi: 10.3349/ymj.2016.57.4.915.

29.

An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center.

Gabriel PE, Woodhouse KD, Lin A, Finlay JC, Young RB, Volz E, Hahn SM, Metz JM, Maity A.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e307-e314. doi: 10.1016/j.prro.2016.03.004. Epub 2016 Mar 16.

PMID:
27155763
30.

Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control.

Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, Chang JY, Hahn SM, Welsh JW.

Cancer J. 2016 Mar-Apr;22(2):130-7. doi: 10.1097/PPO.0000000000000181. Review.

PMID:
27111909
31.

Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.

Baumann BC, Nagda SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB 2nd.

J Surg Oncol. 2016 Jul;114(1):65-9. doi: 10.1002/jso.24268. Epub 2016 Apr 25.

PMID:
27111504
32.

Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.

Gameiro SR, Malamas AS, Bernstein MB, Tsang KY, Vassantachart A, Sahoo N, Tailor R, Pidikiti R, Guha CP, Hahn SM, Krishnan S, Hodge JW.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):120-30. doi: 10.1016/j.ijrobp.2016.02.022. Epub 2016 Feb 13.

33.

Journey Toward High Reliability: A Comprehensive Safety Program to Improve Quality of Care and Safety Culture in a Large, Multisite Radiation Oncology Department.

Woodhouse KD, Volz E, Maity A, Gabriel PE, Solberg TD, Bergendahl HW, Hahn SM.

J Oncol Pract. 2016 May;12(5):e603-12. doi: 10.1200/JOP.2015.008466. Epub 2016 Mar 29.

PMID:
27026647
34.

Symptom Interval and Patient Delay Affect Survival Outcomes in Adolescent Cancer Patients.

Jin SL, Hahn SM, Kim HS, Shin YJ, Kim SH, Lee YS, Lyu CJ, Han JW.

Yonsei Med J. 2016 May;57(3):572-9. doi: 10.3349/ymj.2016.57.3.572.

35.

Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network.

Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ Jr, Martinez W, Hahn SM, Famiglietti R, Kuban DA.

J Oncol Pract. 2016 Apr;12(4):e476-86. doi: 10.1200/JOP.2015.005983. Epub 2016 Mar 1.

PMID:
26931402
36.

Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma.

Hahn SM, Kim HS, Kim DJ, Lee SC, Lyu CJ, Han JW.

Pediatr Hematol Oncol. 2016 Feb;33(1):74-82. doi: 10.3109/08880018.2015.1135363. Epub 2016 Feb 22.

PMID:
26901285
37.

The implementation and assessment of a quality and safety culture education program in a large radiation oncology department.

Woodhouse KD, Volz E, Bellerive M, Bergendahl HW, Gabriel PE, Maity A, Hahn SM, Vapiwala N.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e127-34. doi: 10.1016/j.prro.2015.11.011. Epub 2015 Nov 17.

PMID:
26850651
38.

Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs.

Grover S, Raesima M, Bvochora-Nsingo M, Chiyapo SP, Balang D, Tapela N, Balogun O, Kayembe MK, Russell AH, Monare B, Tanyala S, Bhat J, Thipe K, Nchunga M, Mayisela S, Kizito B, Ho-Foster A, Gaolebale BE, Gaolebale PA, Efstathiou JA, Dryden-Peterson S, Zetola N, Hahn SM, Robertson ES, Lin LL, Morroni C, Ramogola-Masire D.

Front Oncol. 2015 Nov 3;5:239. doi: 10.3389/fonc.2015.00239. eCollection 2015. Review.

39.

Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.

Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC.

Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):391-4. doi: 10.1007/s00417-015-3202-0. Epub 2015 Oct 29.

PMID:
26511530
40.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.

Zindler JD, Thomas CR Jr, Hahn SM, Hoffmann AL, Troost EG, Lambin P.

J Natl Cancer Inst. 2015 Oct 16;108(2). pii: djv305. doi: 10.1093/jnci/djv305. Print 2016 Feb. Review.

PMID:
26476075
41.

A Roadmap for a New Academic Pathway for Global Radiation Oncology.

Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover S.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):493-6. doi: 10.1016/j.ijrobp.2015.06.023. No abstract available.

PMID:
26460990
42.

Technology for Innovation in Radiation Oncology.

Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):485-92. doi: 10.1016/j.ijrobp.2015.07.007. Epub 2015 Jul 11.

43.

Huge retroperitoneal complicated pseudotumour in haemophilia B with inhibitor.

Hahn SY, Hahn SM, Jin SL, Kim HS, Lyu CJ, Lee JG, Han JW.

Haemophilia. 2016 Jan;22(1):e45-7. doi: 10.1111/hae.12799. Epub 2015 Oct 13. No abstract available.

PMID:
26459955
44.

Reply to G. Gandaglia et al and K. Lu.

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SM, Polsky D, Armstrong K.

J Clin Oncol. 2015 Sep 1;33(25):2833. doi: 10.1200/JCO.2015.62.4643. Epub 2015 Jul 27. No abstract available.

PMID:
26215947
45.

Factors associated with event reporting in the pediatric radiation oncology population using an electronic incident reporting system.

Hill-Kayser CE, Gabriel P, Volz E, Lustig RA, Tochner Z, Hahn SM, Maity A.

Pract Radiat Oncol. 2015 Sep-Oct;5(5):e417-e422. doi: 10.1016/j.prro.2015.06.001. Epub 2015 Jul 26.

PMID:
26215584
46.

In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy.

Finlay JC, Zhu TC, Dimofte A, Stripp D, Malkowicz SB, Whittington R, Miles J, Glatstein E, Hahn SM.

Proc SPIE Int Soc Opt Eng. 2014 Jun 14;5315:132-142.

47.

Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem".

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM.

Front Oncol. 2015 Jun 10;5:133. doi: 10.3389/fonc.2015.00133. eCollection 2015.

48.

Society of Chairs of Academic Radiation Oncology Programs-Endorsed Radiation Oncology Department Review Process.

Thomas CR Jr, Bonner JA, Hahn SM, Lawrence TS, Liu FF, Formenti SC; Society of Chairs of Academic Radiation Oncology Programs.

Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):536-9. doi: 10.1016/j.ijrobp.2015.02.040. No abstract available.

PMID:
26068488
49.

Incident learning in pursuit of high reliability: implementing a comprehensive, low-threshold reporting program in a large, multisite radiation oncology department.

Gabriel PE, Volz E, Bergendahl HW, Burke SV, Solberg TD, Maity A, Hahn SM.

Jt Comm J Qual Patient Saf. 2015 Apr;41(4):160-8.

PMID:
25977200
50.

Proton beam therapy: the next disruptive innovation in healthcare?

Swisher-McClure S, Hahn SM, Bekelman J.

Postgrad Med J. 2015 May;91(1075):241-3. doi: 10.1136/postgradmedj-2014-132935. No abstract available.

Supplemental Content

Support Center